In particular, compound 109 displayed strong antiproliferative effects against EGFR mutant-driven non-small cell lung cancer (NSCLC) cell lines such as H1975, PC9, HCC827, and H3255 without obvious toxicity. This evidence concerns the gene EGFR and non-small cell lung carcinoma.